ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Tarsus Pharmaceuticals
The Vice President, Clinical Development provides strategic and scientific leadership across the entire clinical development continuum, from first‑in‑human studies through late‑stage trials and registration. This role shapes clinical strategy, oversees trial design and execution, and builds a high‑performing clinical organization while partnering cross‑functionally with regulatory, medical, commercial, and business development teams.
Tarsus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing novel therapies for diseases with high unmet need, with a primary focus on eye care. The company markets XDEMVY® (lotilaner ophthalmic solution) 0.25%, the first and only FDA-approved treatment for Demodex blepharitis, and has a pipeline targeting conditions such as ocular rosacea and Lyme disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tarsus Pharmaceuticals.
Vice President, Clinical Development
Precision for Medicine
Vice President, Clinical Development
Tango Therapeutics
Senior or Executive Director, Clinical Development
Erasca
Clinical Director Oncology (Principal Scientist, MD)
MSD
Vice President, Clinical Development
Kura Oncology
Vice President, Clinical Development Program Leader (MD)
Madrigal Pharmaceuticals